Skip to content

Effects of Vibration Training on Exercise Capacity in COPD-patients

Effects of Vibration Training During a Three-week Rehabilitation on Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD) III/IV-Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01380639
Enrollment
72
Registered
2011-06-27
Start date
2010-09-30
Completion date
2011-04-30
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD III/IV, 6-Minutes-Walking-Distance, Vibration training, Galileo, Pulmonary rehabilitation

Brief summary

The aim of this study is to investigate the exercise capacity in COPD-patients performing a vibration training additional to a standard three-week rehabilitation program in comparison to patients performing merely a rehabilitation program.

Interventions

OTHERwhole body vibration training

performing squats for 3x3 minutes while using vibration platform three times a week

Sponsors

Schön Klinik Berchtesgadener Land
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Chronic obstructive pulmonary disease III/IV

Exclusion criteria

* Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics)) * Severe disease other than COPD, that could influence the results of the study * Abuse of alcohol or drugs * Simultaneously participation in another study * Tachypnea (\>30/min) * Severe exacerbation during rehabilitation * Cardiac insufficiency (NYHA IV) * Myocardial infarction during the last 6 weeks * Mental-health problem * Pregnancy * Known HIV-infection * Slipped disk * Acute discopathy * Acute thrombosis * Implants in trained regions of the body (lower extremities) * Acute inflammation of the locomotor system, active arthrosis or rheumatoid arthritis * Acute tendinopathy in trained regions of the body * Acute hernia * Fresh fractures, wounds or scars in trained regions of the body * Gallstones or stones in the urinary tract collection system

Design outcomes

Primary

MeasureTime frameDescription
6-Minute-Walking-Distanceday 1, day 19Change in 6-minute-walking-distance from baseline to day 19

Secondary

MeasureTime frameDescription
Body Compositionday 1 and 19Change in body composition from baseline to day 19
Isometric Maximum Handgrip Forceday 1, day 19change in isometric max. handgrip force from baseline to day 19
Brain Natruretic Peptide (BNP)day 1, day 19change in BNP from baseline to day 19
Lung Functionday 1
Arterial Blood Gasday 1
BODE-Scoreday 1, day 19Change in Bode-Score from baseline to day 19

Countries

Germany

Participant flow

Pre-assignment details

Enrollment of patients is meant for the number of study completers without drop out patients (n=10).

Participants by arm

ArmCount
Rehabilitation With Vibration Training
whole body vibration training : performing squats for 3x3 minutes while using vibration platform three times a week
42
Rehabilitation Without Vibration Training40
Total82

Baseline characteristics

CharacteristicRehabilitation Without Vibration TrainingRehabilitation With Vibration TrainingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
21 Participants20 Participants41 Participants
Age, Categorical
Between 18 and 65 years
19 Participants22 Participants41 Participants
Age, Continuous65 years
STANDARD_DEVIATION 7
64 years
STANDARD_DEVIATION 11
64 years
STANDARD_DEVIATION 9
Region of Enrollment
Germany
40 participants42 participants82 participants
Sex: Female, Male
Female
19 Participants23 Participants42 Participants
Sex: Female, Male
Male
21 Participants19 Participants40 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 420 / 40
other
Total, other adverse events
0 / 420 / 40
serious
Total, serious adverse events
0 / 420 / 40

Outcome results

Primary

6-Minute-Walking-Distance

Change in 6-minute-walking-distance from baseline to day 19

Time frame: day 1, day 19

ArmMeasureValue (MEAN)Dispersion
Rehabilitation With Vibration Training6-Minute-Walking-Distance64 mStandard Deviation 59
Rehabilitation Without Vibration Training6-Minute-Walking-Distance37 mStandard Deviation 52
Secondary

Arterial Blood Gas

Time frame: day 1

Secondary

BODE-Score

Change in Bode-Score from baseline to day 19

Time frame: day 1, day 19

Secondary

Body Composition

Change in body composition from baseline to day 19

Time frame: day 1 and 19

Secondary

Brain Natruretic Peptide (BNP)

change in BNP from baseline to day 19

Time frame: day 1, day 19

Secondary

Isometric Maximum Handgrip Force

change in isometric max. handgrip force from baseline to day 19

Time frame: day 1, day 19

Secondary

Lung Function

Time frame: day 1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026